The recognized role of PDGFR and TGF-β pathways in idiopathic pulmonary fibrosis pathogenesis led to subsequent investigations assessing IM as a potential inhibitor of lung fibrosis [14]. Here, TGFB1 is linked to pulmonary fibrosis.